Multiple psychotropic medication use for youths: a two-state comparison

Area of Science:

• Pediatric psychopharmacology
• Health services research
• Child and adolescent psychiatry

Background:

• Psychotropic medication use in youth is increasing.
• Understanding patterns of multiple psychotropic medication use is crucial for optimizing treatment.
• Medicaid and State Children's Health Insurance Programs (SCHIP) cover a significant population of children and adolescents.

Purpose of the Study:

• To compare multiple psychotropic use among youths enrolled in Medicaid and SCHIP programs in two mid-Atlantic states.
• To determine the prevalence and duration of multiple psychotropic medication use in this population.
• To identify demographic and clinical factors associated with multiple psychotropic use.

Main Methods:

• Analysis of administrative data for continuously enrolled youths (<20 years) in 1999.
• Definition of multiple psychotropic use as multiclass combinations and duration in months.
• Examination of mental health visits, demographic, and clinical characteristics.

Main Results:

• 2-3% of continuously enrolled youths received multiple psychotropic medications.
• 28-30% of youths with any psychotropic use received multiple medications, with nearly half for 5-12 months.
• Multiclass use was more prevalent in males, white youths, those aged 10-14, disabled, and foster care youths. Stimulants with antidepressants, antipsychotics, or alpha-agonists were common combinations.

Conclusions:

• Multiple psychotropic medication use is common among youths receiving psychiatric treatment.
• Further research is needed on medication switching patterns and the efficacy of combined pharmacotherapy in pediatric populations.
• Findings highlight the need for careful monitoring and evaluation of complex psychotropic regimens in youth.